Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
51 - 60 out of 68Page size: 10
Sort by: 1st author
  1. Published

    Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

    Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J. V., Bakris, G. L., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, Peter, Tobe, S., Parving, H. H., de Zeeuw, D. & Heerspink, H. J. L., 2022, In: Clinical Pharmacology and Therapeutics. 112, 5, p. 1098-1107

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes

    Stougaard, E. B., Rossing, Peter, Vistisen, D., Banks, P., Girard, M., Davies, M. J. & Persson, F., 2022, In: Diabetologia. 65, SUPPL 1, p. S47 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  3. Published

    Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

    Stougaard, E. B., Kristensen, Peter Lommer, Kielgast, U., Andersen, H. U., Hamid, Y., Gæde, P. H., Søndergaard, E., Dørflinger, G. H., Fjeldborg, K. K., Hansen, K. W., Thomsen, H. H., Al-Imar, T. M. J., Røder, M., Sridhar, V. S., Cherney, D., Rossing, Peter & Persson, F., 2022, In: Diabetes & vascular disease research. 19, 5, p. 14791641221130043

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

    Stougaard, E. B., Rossing, Peter, Cherney, D., Vistisen, D. & Persson, F., 2022, In: Journal of Diabetes and its Complications. 36, 8, 108257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Tougaard, N. H., Frimodt-Møller, M., Salmenkari, H., Stougaard, E. B., Zawadzki, A. D., Mattila, I. M., Hansen, T. W., Legido-Quigley, C., Hörkkö, S., Forsblom, C., Groop, P. H., Lehto, M. & Rossing, Peter, 2022, In: Journal of Clinical Medicine. 11, 13, 3573.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

    Tougaard, N. H., Møller, A. L., Rønn, P. F., Hansen, T. W., Genovese, F., Karsdal, M. A., Rasmussen, D. G. K. & Rossing, Peter, Nov 2022, In: Diabetes Care. 45, 11, p. 2746-2748 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions

    Vart, P., Correa-Rotter, R., Hou, F. F., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Douthat, W., Escudero, E., Isidto, R., Khullar, D., Bajaj, H. S., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Kidney International Reports. 7, 4, p. 699-707 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

    Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G. M., Jongs, N., Langkilde, A. M., Mann, J. F. E., Mosenzon, O., McMurray, J. J. V., Rossing, Peter, Correa-Rotter, R., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetologia. 65, 7, p. 1085-1097 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

    Waijer, S. W., Provenzano, M., Mulder, S., Rossing, Peter, Persson, F., Perkovic, V. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 6, p. 983-990 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

    Wheeler, D. C., Jongs, N., Stefansson, B., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J., Rossing, Peter, Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjostrom, C. D., Toto, R. D., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2022, In: Nephrology Dialysis Transplantation. 37, 9, p. 1647–1656 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 Next

ID: 12937790